The landscape of computational biology has shifted dramatically in recent years. By 2026, the integration of artificial intelligence into protein engineering has moved beyond theoretical exercises into robust, commercial-grade applications. This guide explores the state-of-the-art tools transforming structure prediction, de novo design, and antibody engineering.<img src="https://ezycourse.b-cdn.net/2858/cmjzwe1llwpo09z9n1oet6pn1.png" containerstyle="position: relative; width: 663px; height: auto; cursor: pointer;" alt="image"><img src="https://ezycourse.b-cdn.net/2858/cmjzw1g8xwz0o6r9n5cb01pg8.png" containerstyle="position: relative; width: 661px; height: auto; cursor: pointer;" alt="image"><h2 id="2ddc2428-15a4-4e2e-8802-b1515d969ee6" data-toc-id="2ddc2428-15a4-4e2e-8802-b1515d969ee6" style="font-size: 24px; font-weight: 600; line-height: 1.2;">The Evolution of Structure Prediction</h2>While AlphaFold2 remains the progenitor of the explosion in biological machine learning (BioML), 2026 has seen the rise of specialised alternatives, particularly given the commercial restrictions on DeepMind's AlphaFold3.<img src="https://ezycourse.b-cdn.net/2858/cmjzw2oahwljqk18z4ipe1cb1.png" containerstyle="position: relative; width: 650px; height: auto; cursor: pointer;" alt="image">For researchers requiring commercial utility and improved accuracy in specific niches, two key tools have emerged as standard-bearers:<ul><li>Chai-1: This tool introduces restraints that allow for the description of binding sites between proteins. It supports substantially increased docking accuracy, making it particularly useful for immunoglobulins (Igs).</li><li>Boltz-2: Offering specific improvements for the physical accuracy of protein-small molecule complexes, this tool is recommended for enzymes or small molecules targeting proteins. It is also capable of predicting binding affinity.</li></ul>For those working with antibody-antigen complexes, AlphaFold3+Rosetta currently represents the highest quality docking protocol available.<h2 id="7039da01-8cb8-42b0-8134-d4ca4a677289" data-toc-id="7039da01-8cb8-42b0-8134-d4ca4a677289" style="font-size: 24px; font-weight: 600; line-height: 1.2;">1) De Novo Design: From Miniproteins to Enzymes</h2>The generation of proteins from "close to nothing" - typically using only a target molecule as input - has seen an explosion in success rates, moving from one in ten thousand to double-digit hit rates.<img src="https://ezycourse.b-cdn.net/2858/cmjzw63jywxpz6o9n31udfoju.png" containerstyle="position: relative; width: 654px; height: auto; cursor: pointer;" alt="image"><h3 id="d2123895-de84-4312-8a78-9f8b829337dc" data-toc-id="d2123895-de84-4312-8a78-9f8b829337dc" style="font-size: 20px; font-weight: 600; line-height: 1.2;">Miniproteins and Antibodies</h3>Miniproteins (50–200 residues) have proven uniquely successful. Tools like BindCraft allow designs to achieve 10–100% hit rates with high affinity (median KD 1–30 nM) after a single round of expression.For antibodies, tools such as Boltzgen, Germinal, and RFantibody are delivering reliable hit rates of up to 10–20% against diverse targets. Notably, mBER leverages structural templates within the ColabDesign framework to produce high-affinity VHH binders.<h3 id="51053d80-b576-47ad-8420-e9067fbaf24f" data-toc-id="51053d80-b576-47ad-8420-e9067fbaf24f" style="font-size: 20px; font-weight: 600; line-height: 1.2;">Enzyme Engineering</h3>The combination of RFdiffusion, LigandMPNN, and PLACER has set a new standard. By growing protein backbones around specified active sites, researchers have produced crystal-validated enzymes with high catalytic efficiencies without needing directed evolution.<h2 id="cfb18f83-66ea-4aa2-8e84-f5b2975086e7" data-toc-id="cfb18f83-66ea-4aa2-8e84-f5b2975086e7" style="font-size: 24px; font-weight: 600; line-height: 1.2;">2) Inverse Folding and Sequence Optimisation</h2>Once a structure is defined, the challenge shifts to "inverse folding"—predicting a sequence that will fold into that structure. The gold standard in this domain remains ProteinMPNN, which replaces residues to improve solubility and stability.<img src="https://ezycourse.b-cdn.net/2858/cmjzw51n2x0d06r9na36ncch6.png" containerstyle="position: relative; width: 648px; height: auto; cursor: pointer;" alt="image">Key variations of this technology include:<ul><li>SolubleMPNN: Specialised for soluble proteins, yielding interesting results in GPCR solubilisation.</li><li>AntiFold &amp; IgDesign: Optimised for antibody-antigen complexes to replace CDRs for improved binding affinity.</li><li>ThermoMPNN: Scores point mutations for their effect on stability (ddG), correlating well with wet lab results.</li></ul><h2 id="43aa46ff-a52c-42a9-87a6-debccc96fe31" data-toc-id="43aa46ff-a52c-42a9-87a6-debccc96fe31" style="font-size: 24px; font-weight: 600; line-height: 1.2;">3) The Rise of Peptide Design</h2>De novo design for linear and cyclic peptides has become significantly more reliable. BindCraft has demonstrated strong hits on targets like MDM2, and RFpeptides has produced high-affinity binders (including sub-nM binders) starting from sequence alone. Additionally, PepMLM offers a sequence-only method for designing linear peptide binders capable of driving targeted degradation.<img src="https://ezycourse.b-cdn.net/2858/cmjzwcenwxbtm8y9n40t45dmi.png" containerstyle="position: relative; width: 736px; height: auto; cursor: pointer;" alt="image"><h2 id="a3c142c0-e404-4498-ae47-326d1b678ac9" data-toc-id="a3c142c0-e404-4498-ae47-326d1b678ac9" style="font-size: 24px; font-weight: 600; line-height: 1.2;">Assessing Developability and Liabilities</h2>Creating a binder is only half the battle; it must also be developable. Modern workflows integrate machine learning to score physical properties:<ul><li>Therapeutic Antibody Profiler (TAP): Compares physics-based features of a candidate against clinical-stage antibodies to flag developability risks.</li><li>BioPhi: Uses statistical methods to predict regions requiring modification for effective humanisation while maintaining affinity.</li><li>DeepImmuno: Predicts the immunogenicity of peptide/HLA combinations.</li></ul><hr><img src="https://ezycourse.b-cdn.net/2858/cmjzwfk44dysxee8z03pp051i.png" containerstyle="position: relative; width: 660px; height: auto; cursor: pointer;" alt="image"><h2 id="e176b99a-a022-4ecb-9370-3685d7716914" data-toc-id="e176b99a-a022-4ecb-9370-3685d7716914" style="font-size: 24px; font-weight: 600; line-height: 1.2;">Frequently Asked Questions</h2>Q: What is the best alternative to AlphaFold3 for commercial use? A: Since AlphaFold3 does not allow commercial use, groups have released reproductions. Chai-1 is a strong alternative for docking accuracy, and Boltz-2 is recommended for protein-small molecule complexes.Q: What is inverse folding in protein design? A: Inverse folding is the process of going from a protein structure to a novel sequence predicted to fold into that structure. Tools like ProteinMPNN are used to generate sequences that are often more soluble and stable than the native sequence.Q: Can AI design enzymes from scratch? A: Yes. Protocols using RFdiffusion to scaffold around active sites, followed by LigandMPNN for sequencing and PLACER for vetting, have produced catalytically active enzymes with high efficiency without directed evolution.Q: How accurate are current de novo antibody design tools? A: Recent advancements have raised success rates from 1 in 10,000 to double digits. Tools like BoltzGen have achieved 60–70% success rates for nanobody binders against novel targets with limited designs tested.Q: What tools are available for peptide binder design? A: Leading tools for peptide design include BindCraft (structure-based filtering), RFpeptides (diffusion-based), and PepMLM (sequence-only design).

AI protein design, featuring commercial AlphaFold alternatives like Chai-1 and Boltz-2. Explore cutting-edge tools for de novo antibody generation, enzyme engineering, and inverse folding

The 2026 Guide to AI for Proteins: Tools, Trends, and Techniques

1) De Novo Design: From Miniproteins to Enzymes

2) Inverse Folding and Sequence Optimisation

Read the Scidart Academy blog for tips, insights, and resources on scientific research, career development, scientific illustration, computational tools, and science communication for researchers and engineers.

Blog | Scidart Academy – Science, Research & Career Tips for Scientists

Explore the Scidart Academy blog – expert articles on scientific illustration, research tools, career growth, and science communication for the global research community.

The 2026 Guide to AI for Proteins: Tools, Trends, and Techniques

The 2026 Guide to AI for Proteins: Tools, Trends, and Techniques

Related Posts

ChemSketch Alternative: 7 Free Chemical Drawing Tools to Try in 2026

56 Best Research Tools Every Researcher Should Know in 2026

Best GraphPad Prism Alternatives in 2026: 10 Powerful Tools for Scientific Data Analysis and Publication Ready Graphs

Searching for a MolView Alternative? Why MolDraw.com is the Perfect Companion

SciSpace Just Launched a Dedicated BioMed Agent: A Deep Dive into the New AI Co-Scientist